Description
- Peptide research reagent
- Designed for laboratory applications
- Clearly labeled packaging
- Suitable for controlled experimental work
- Professional product handling
- Research-focused supply
Technical Specifications
| Specification | Value |
|---|---|
| Product | BPC-157 |
| Classification | Synthetic pentadecapeptide |
| Sequence | GEPPPGKPADDAGLV |
| CAS | 137525-51-0 |
| Molecular Weight | ~1419.5 g/mol |
| Form | Lyophilized powder |
| Intended Use | Laboratory research |
Literature
What researchers are studying
Research has explored BPC-157 in models involving blood-vessel growth, fibroblast activity, nitric-oxide signalling, muscle and tendon repair, and inflammatory responses. The strongest body of evidence remains animal and laboratory research, with human data still limited.
Selected Literature
- Biopharmaceutical and development review — PubMed View PubMed publication
- Orthopaedic/sports-medicine systematic review — PubMed View PubMed publication
- Review of regenerative potential and evidence gaps — PubMed View PubMed publication
COA Documentation
This trial lot has been qualified using supplier documentation and the supplier-provided lot-specific COA. Independent Canadian laboratory confirmation has not been completed.
Frequently Asked Questions
Key information about BPC-157, research status, documentation, and intended use.
BPC-157 is a synthetic peptide studied in laboratory and preclinical research involving muscle and tendon repair and inflammatory responses.
Research has looked at tissue signalling, blood-vessel growth, inflammation, and musculoskeletal models.
No. Human evidence remains limited, and the compound should be treated as investigational.
Yes. Supplier-provided Certificate of Analysis documentation may be available for the applicable lot.
No. This product is intended for laboratory research purposes only and is not intended for human use.







Reviews